BIOREPOSITORY_STUDY_NO,AGE_AT_DX_YRS,BIRTH_DT,CANCER_STUDY_ID,DIAGNOSIS_DT,EMPI,FCILTY_ID,SEX_CD,RACE_CD,RACE_DSC,DX_CODE_CD,PRIMARY_HISTOLOGY_DSC,GRADE_DSC,PATH_STAGE_DSC,TUMOR_SIZE_VAL,NSN_EXAMINED_CNT,NSN_POSITIVE_CNT,T_DSC,N_DSC,M_DSC,M_CLIN_DSC,TEST_DT,TEST_TYPE_DSC,RESULT_DSC,TX_TYPE_DSC,TX_REASON_DSC,AGENT_DSC,START_DT,END_DT,PROGRESSION_DT,DOSE_DELIVERY_DSC,DOSE_VAL,NO_TX_REASON_DSC,PATIENT_STATUS_DSC,DEATH_DT,CAUSE_OF_DEATH_DSC,RECURRENCE_DT,RECURRENCE_SITE
CR-012,65,7-Feb-44,25828,30-Jun-08,204,126,M,1,WHITE,C187,"Adenocarcinoma, NOS",2,IIIB,5,26,1,T3,N1,MX,M0,,,,Chemotherapy,Adjuvant,,,,,,,Unknown,Dead,3-Dec-13,Unrelated to Disease,,
CR-013,28,15-Nov-80,25829,13-Sep-07,221,126,M,1,WHITE,C182,"Adenocarcinoma, NOS",2,IIIB,9,22,2,T3,N1,MX,M0,,,,Chemotherapy,Adjuvant,Capecitabine                                                            ,,,,,,"Received treatment out of system, no information available",Dead,30-May-12,Unrelated to Disease,,
CR-014,68,16-Feb-41,25830,15-Mar-08,238,126,F,1,WHITE,C184,"Adenocarcinoma, NOS",3,IIIB,6,21,10,T3,N2,MX,M0,,,,Chemotherapy,1st Line,Erbitux,,,,,,"Received treatment out of system, no information available",Dead,10-Jun-10,Primary Cancer,29-Sep-08,Soft Tissue
CR-014,68,16-Feb-41,25830,15-Mar-08,238,126,F,1,WHITE,C184,"Adenocarcinoma, NOS",3,IIIB,6,21,10,T3,N2,MX,M0,,,,Chemotherapy,2nd Line,Erbitux,,,,,,"Received treatment out of system, no information available",Dead,10-Jun-10,Primary Cancer,29-Sep-08,Soft Tissue
CR-014,68,16-Feb-41,25830,15-Mar-08,238,126,F,1,WHITE,C184,"Adenocarcinoma, NOS",3,IIIB,6,21,10,T3,N2,MX,M0,,,,Chemotherapy,2nd Line,Irinotecan Hydrochloride                                                ,,,,,,"Received treatment out of system, no information available",Dead,10-Jun-10,Primary Cancer,29-Sep-08,Soft Tissue
CR-014,68,16-Feb-41,25830,15-Mar-08,238,126,F,1,WHITE,C184,"Adenocarcinoma, NOS",3,IIIB,6,21,10,T3,N2,MX,M0,,,,Chemotherapy,Adjuvant,,,,,,,"Received treatment out of system, no information available",Dead,10-Jun-10,Primary Cancer,29-Sep-08,Soft Tissue
CR-015,11,31-Oct-96,25831,5-Aug-06,255,126,F,1,WHITE,C180,"Adenocarcinoma, NOS",3,IIIB,7,15,10,T3,N2,MX,M0,,,,Chemotherapy,1st Line,Capecitabine                                                            ,,,,,,"Received treatment out of system, no information available",Dead,10-Nov-07,Primary Cancer,30-Apr-07,Soft Tissue
CR-015,11,31-Oct-96,25831,5-Aug-06,255,126,F,1,WHITE,C180,"Adenocarcinoma, NOS",3,IIIB,7,15,10,T3,N2,MX,M0,,,,Chemotherapy,Adjuvant,,,,,,,Unknown,Dead,10-Nov-07,Primary Cancer,30-Apr-07,Soft Tissue
CR-016,17,14-Jan-95,25832,23-May-11,272,126,M,1,WHITE,C187,Mucinous adenocarcinoma,3,IIIB,9,17,1,T3,N1a,MX,M0,,,,Chemotherapy,1st Line,Capecitabine                                                            ,5-Nov-12,6-Mar-13,11-Mar-13,,,,Dead,16-Mar-13,Primary Cancer,22-Feb-12,Lung
CR-016,17,14-Jan-95,25832,23-May-11,272,126,M,1,WHITE,C187,Mucinous adenocarcinoma,3,IIIB,9,17,1,T3,N1a,MX,M0,,,,Chemotherapy,1st Line,Oxaliplatin                                                             ,5-Nov-12,6-Mar-13,11-Mar-13,,,,Dead,16-Mar-13,Primary Cancer,22-Feb-12,Lung
CR-016,17,14-Jan-95,25832,23-May-11,272,126,M,1,WHITE,C187,Mucinous adenocarcinoma,3,IIIB,9,17,1,T3,N1a,MX,M0,,,,Chemotherapy,Adjuvant,,,,,,,Patient choice,Dead,16-Mar-13,Primary Cancer,22-Feb-12,Lung
CR-017,48,14-Mar-60,25833,7-Feb-07,289,126,M,1,WHITE,C187,"Adenocarcinoma, NOS",2,IIIC,6,10,5,T3,N2,MX,M0,,,,Chemotherapy,Adjuvant,,,,,,,Patient choice,Dead,21-Jan-10,Primary Cancer,22-Oct-08,Local/Regional
CR-017,48,14-Mar-60,25833,7-Feb-07,289,126,M,1,WHITE,C187,"Adenocarcinoma, NOS",2,IIIC,6,10,5,T3,N2,MX,M0,,,,Chemotherapy,1st Line,,,,,,,Patient choice,Dead,21-Jan-10,Primary Cancer,22-Oct-08,Local/Regional
CR-018,77,27-Aug-32,25834,15-Jan-08,306,126,F,1,WHITE,C184,"Adenocarcinoma, NOS",2,IIIC,10,19,4,T3,N2,MX,M0,,,,Radiation,1st Line,,4-Jun-09,4-Jun-09,10-May-10,,,,Dead,25-Jan-12,Primary Cancer,18-May-09,Liver
CR-018,77,27-Aug-32,25834,15-Jan-08,306,126,F,1,WHITE,C184,"Adenocarcinoma, NOS",2,IIIC,10,19,4,T3,N2,MX,M0,,,,Chemotherapy,Adjuvant,,,,,,,Not recommended due to age/co-morbidities,Dead,25-Jan-12,Primary Cancer,18-May-09,Liver
CR-019,69,2-Aug-39,25835,17-Apr-07,323,126,M,1,WHITE,C187,Mucinous adenocarcinoma,2,IIIB,6,16,1,T3,N1,MX,M0,,,,Chemotherapy,1st Line,Cetuximab                                                               ,21-Jan-10,4-Apr-10,,,,,Dead,1-Oct-10,Complications of Treatment,14-Oct-08,Soft Tissue
CR-019,69,2-Aug-39,25835,17-Apr-07,323,126,M,1,WHITE,C187,Mucinous adenocarcinoma,2,IIIB,6,16,1,T3,N1,MX,M0,,,,Chemotherapy,1st Line,Irinotecan Hydrochloride                                                ,21-Jan-10,4-Apr-10,,,,,Dead,1-Oct-10,Complications of Treatment,14-Oct-08,Soft Tissue
CR-019,69,2-Aug-39,25835,17-Apr-07,323,126,M,1,WHITE,C187,Mucinous adenocarcinoma,2,IIIB,6,16,1,T3,N1,MX,M0,,,,Chemotherapy,2nd Line,Panitumumab                                                             ,30-Mar-10,16-Jul-10,21-Sep-10,,,,Dead,1-Oct-10,Complications of Treatment,14-Oct-08,Soft Tissue
CR-019,69,2-Aug-39,25835,17-Apr-07,323,126,M,1,WHITE,C187,Mucinous adenocarcinoma,2,IIIB,6,16,1,T3,N1,MX,M0,,,,Chemotherapy,Adjuvant,FOLFOX,17-Oct-07,23-Jan-08,,,,,Dead,1-Oct-10,Complications of Treatment,14-Oct-08,Soft Tissue
CR-020,36,27-Nov-73,25836,20-Feb-08,340,126,F,1,WHITE,C182,"Adenocarcinoma, NOS",3,IIIC,4,21,7,T3,N2,MX,M0,,,,Chemotherapy,Adjuvant,,,,,,,Not recommended,Dead,24-Apr-09,Unknown cause but with Disease,16-Sep-08,Liver
CR-021,78,21-Sep-36,25837,30-Jan-13,357,126,F,1,WHITE,C182,"Adenocarcinoma, NOS",3,IIIB,4,4,3,T3,N1b,MX,M0,,,,Chemotherapy,Adjuvant,Capecitabine                                                            ,2-Apr-13,16-Apr-13,,,,,Dead,5-May-13,Complications of Treatment,,
CR-022,58,11-Apr-52,25838,2-Sep-09,374,126,M,1,WHITE,C182,"Adenocarcinoma, NOS",2,IIIB,4,7,2,T3,N1,MX,M0,,,,Chemotherapy,Adjuvant,FOLFOX,30-Sep-09,2-Mar-10,,,,,Dead,1-Jul-11,Unrelated to Disease,,
CR-023,41,31-May-65,25839,18-Nov-05,391,126,M,1,WHITE,C187,"Adenocarcinoma, NOS",2,IIIC,6,15,5,T3,N2a,MX,M0,18-Nov-05,KRAS,Positive,Chemotherapy,1st Line,FOLFOX,,,09-Jul-10,,,"Received treatment out of system, no information available",Dead,22-Apr-11,Primary Cancer,23-Feb-09,Lung
CR-023,41,31-May-65,25839,18-Nov-05,391,126,M,1,WHITE,C187,"Adenocarcinoma, NOS",2,IIIC,6,15,5,T3,N2a,MX,M0,18-Nov-05,KRAS,Positive,Chemotherapy,1st Line,FOLFIRI,,,09-Jul-10,,,"Received treatment out of system, no information available",Dead,22-Apr-11,Primary Cancer,23-Feb-09,Lung
CR-023,41,31-May-65,25839,18-Nov-05,391,126,M,1,WHITE,C187,"Adenocarcinoma, NOS",2,IIIC,6,15,5,T3,N2a,MX,M0,18-Nov-05,KRAS,Positive,Chemotherapy,1st Line,Bevacizumab                                                             ,,,09-Jul-10,,,"Received treatment out of system, no information available",Dead,22-Apr-11,Primary Cancer,23-Feb-09,Lung
CR-023,41,31-May-65,25839,18-Nov-05,391,126,M,1,WHITE,C187,"Adenocarcinoma, NOS",2,IIIC,6,15,5,T3,N2a,MX,M0,18-Nov-05,KRAS,Positive,Chemotherapy,2nd Line,Capecitabine                                                            ,22-Jul-10,26-Oct-10,09-Nov-10,,,,Dead,22-Apr-11,Primary Cancer,23-Feb-09,Lung
CR-023,41,31-May-65,25839,18-Nov-05,391,126,M,1,WHITE,C187,"Adenocarcinoma, NOS",2,IIIC,6,15,5,T3,N2a,MX,M0,18-Nov-05,KRAS,Positive,Chemotherapy,2nd Line,Bevacizumab                                                             ,22-Jul-10,26-Oct-10,09-Nov-10,,,,Dead,22-Apr-11,Primary Cancer,23-Feb-09,Lung
CR-023,41,31-May-65,25839,18-Nov-05,391,126,M,1,WHITE,C187,"Adenocarcinoma, NOS",2,IIIC,6,15,5,T3,N2a,MX,M0,18-Nov-05,KRAS,Positive,Chemotherapy,Adjuvant,FOLFOX,,,,,,"Received treatment out of system, no information available",Dead,22-Apr-11,Primary Cancer,23-Feb-09,Lung
CR-024,23,30-Dec-85,25840,13-Dec-07,408,126,F,1,WHITE,C184,"Adenocarcinoma, NOS",3,IIIC,9,17,10,T4b,N2b,MX,M0,,,,Chemotherapy,Adjuvant,,,,,,,Patient expired prior to starting treatment,Dead,16-Dec-07,Unrelated to Disease,,
CR-025,73,22-Mar-39,25841,8-Sep-11,425,126,F,1,WHITE,C180,"Adenocarcinoma, NOS",2,IIIB,2,15,5,T2,N2a,MX,M0,,,,Chemotherapy,Adjuvant,,,,,,,Patient expired prior to starting treatment,Dead,28-Sep-11,Unrelated to Disease,,
CR-026,58,27-Jul-51,25842,30-Apr-08,442,126,F,1,WHITE,C187,"Adenocarcinoma, NOS",2,IIIC,3,18,8,T3,N2,MX,M0,,,,Chemotherapy,Adjuvant,,,,,,,Unknown,Dead,4-Dec-10,Unknown cause but with Disease,22-Jan-09,Liver
CR-026,58,27-Jul-51,25842,30-Apr-08,442,126,F,1,WHITE,C187,"Adenocarcinoma, NOS",2,IIIC,3,18,8,T3,N2,MX,M0,,,,Chemotherapy,1st Line,,,,,,,Unknown,Dead,4-Dec-10,Unknown cause but with Disease,22-Jan-09,Liver
CR-027,20,25-Mar-88,25843,11-Aug-07,459,126,F,1,WHITE,C180,"Adenocarcinoma, NOS",2,IIIC,4,24,4,T3,N2,MX,M0,,,,Chemotherapy,Adjuvant,,,,,,,Not recommended due to age/co-morbidities,Dead,17-Jun-13,Unknown cause and unknown Disease Status,,
CR-028,28,20-May-87,25844,28-Oct-14,476,126,M,1,WHITE,C187,"Adenocarcinoma, NOS",2,IIIB,5,18,4,T3,N2a,MX,M0,28-Oct-14,PMS2,Negative,Chemotherapy,Adjuvant,,,,,,,Patient expired prior to starting treatment,Dead,27-Nov-14,Unrelated to Disease,,
CR-028,28,20-May-87,25844,28-Oct-14,476,126,M,1,WHITE,C187,"Adenocarcinoma, NOS",2,IIIB,5,18,4,T3,N2a,MX,M0,28-Oct-14,MSH6,Negative,Chemotherapy,Adjuvant,,,,,,,Patient expired prior to starting treatment,Dead,27-Nov-14,Unrelated to Disease,,
CR-028,28,20-May-87,25844,28-Oct-14,476,126,M,1,WHITE,C187,"Adenocarcinoma, NOS",2,IIIB,5,18,4,T3,N2a,MX,M0,28-Oct-14,MSH2,Negative,Chemotherapy,Adjuvant,,,,,,,Patient expired prior to starting treatment,Dead,27-Nov-14,Unrelated to Disease,,
CR-028,28,20-May-87,25844,28-Oct-14,476,126,M,1,WHITE,C187,"Adenocarcinoma, NOS",2,IIIB,5,18,4,T3,N2a,MX,M0,28-Oct-14,MLH1,Negative,Chemotherapy,Adjuvant,,,,,,,Patient expired prior to starting treatment,Dead,27-Nov-14,Unrelated to Disease,,
CR-029,79,7-Jan-37,25845,5-Mar-15,493,126,F,1,WHITE,C187,"Adenocarcinoma, NOS",2,IIIB,3,9,5,T3,N2a,MX,M0,5-Mar-15,PMS2,Negative,Chemotherapy,Adjuvant,,,,,,,Patient choice,Dead,15-Nov-15,Unknown cause but with Disease,23-Sep-15,Lung
CR-029,79,7-Jan-37,25845,5-Mar-15,493,126,F,1,WHITE,C187,"Adenocarcinoma, NOS",2,IIIB,3,9,5,T3,N2a,MX,M0,5-Mar-15,PMS2,Negative,Chemotherapy,1st Line,,,,,,,Patient choice,Dead,15-Nov-15,Unknown cause but with Disease,23-Sep-15,Lung
CR-029,79,7-Jan-37,25845,5-Mar-15,493,126,F,1,WHITE,C187,"Adenocarcinoma, NOS",2,IIIB,3,9,5,T3,N2a,MX,M0,5-Mar-15,MSH2,Negative,Chemotherapy,Adjuvant,,,,,,,Patient choice,Dead,15-Nov-15,Unknown cause but with Disease,23-Sep-15,Lung
CR-029,79,7-Jan-37,25845,5-Mar-15,493,126,F,1,WHITE,C187,"Adenocarcinoma, NOS",2,IIIB,3,9,5,T3,N2a,MX,M0,5-Mar-15,MSH2,Negative,Chemotherapy,1st Line,,,,,,,Patient choice,Dead,15-Nov-15,Unknown cause but with Disease,23-Sep-15,Lung
CR-029,79,7-Jan-37,25845,5-Mar-15,493,126,F,1,WHITE,C187,"Adenocarcinoma, NOS",2,IIIB,3,9,5,T3,N2a,MX,M0,5-Mar-15,MLH1,Negative,Chemotherapy,Adjuvant,,,,,,,Patient choice,Dead,15-Nov-15,Unknown cause but with Disease,23-Sep-15,Lung
CR-029,79,7-Jan-37,25845,5-Mar-15,493,126,F,1,WHITE,C187,"Adenocarcinoma, NOS",2,IIIB,3,9,5,T3,N2a,MX,M0,5-Mar-15,MLH1,Negative,Chemotherapy,1st Line,,,,,,,Patient choice,Dead,15-Nov-15,Unknown cause but with Disease,23-Sep-15,Lung
CR-029,79,7-Jan-37,25845,5-Mar-15,493,126,F,1,WHITE,C187,"Adenocarcinoma, NOS",2,IIIB,3,9,5,T3,N2a,MX,M0,5-Mar-15,MSH6,Negative,Chemotherapy,Adjuvant,,,,,,,Patient choice,Dead,15-Nov-15,Unknown cause but with Disease,23-Sep-15,Lung
CR-029,79,7-Jan-37,25845,5-Mar-15,493,126,F,1,WHITE,C187,"Adenocarcinoma, NOS",2,IIIB,3,9,5,T3,N2a,MX,M0,5-Mar-15,MSH6,Negative,Chemotherapy,1st Line,,,,,,,Patient choice,Dead,15-Nov-15,Unknown cause but with Disease,23-Sep-15,Lung
CR-030,41,11-Nov-65,25527,24-Oct-05,510,126,F,1,WHITE,C182,"Adenocarcinoma, NOS",2,IIIB,2,43,2,T3,N1,MX,M0,,,,Chemotherapy,Adjuvant,,,,,,,Patient choice,Dead,15-Jun-06,Unknown cause but with Disease,1-Mar-06,Liver
CR-031,36,11-Sep-70,25528,17-Feb-05,527,126,F,1,WHITE,C186,"Adenocarcinoma, NOS",2,IIIB,4,9,7,T3,N2,MX,M0,,,,Chemotherapy,Adjuvant,,,,,,,Unknown,Dead,30-Mar-08,Unknown cause but with Disease,27-Sep-07,Liver
CR-031,36,11-Sep-70,25528,17-Feb-05,527,126,F,1,WHITE,C186,"Adenocarcinoma, NOS",2,IIIB,4,9,7,T3,N2,MX,M0,,,,Chemotherapy,1st Line,,,,,,,Unknown,Dead,30-Mar-08,Unknown cause but with Disease,27-Sep-07,Liver
CR-032,32,19-Nov-82,25529,21-Jan-13,544,126,M,1,WHITE,C187,"Adenocarcinoma, NOS",2,IIIB,4,15,1,T4a,N1c,MX,M0,,,,Chemotherapy,Adjuvant,,,,,,,Not recommended,Dead,27-May-15,Primary Cancer,7-May-15,Soft Tissue
CR-032,32,19-Nov-82,25529,21-Jan-13,544,126,M,1,WHITE,C187,"Adenocarcinoma, NOS",2,IIIB,4,15,1,T4a,N1c,MX,M0,,,,Chemotherapy,1st Line,,,,,,,Not recommended,Dead,27-May-15,Primary Cancer,7-May-15,Soft Tissue
CR-033,57,10-Dec-55,25530,1-Sep-11,561,154,M,1,WHITE,C180,"Adenocarcinoma, NOS",3,IIIB,9,26,3,T3,N1b,MX,M0,26-Sep-11,MLH1,Negative,Chemotherapy,Adjuvant,Capecitabine                                                            ,17-Oct-11,17-Apr-12,,,,,Dead,22-Mar-16,Unrelated to Disease,,
CR-033,57,10-Dec-55,25530,1-Sep-11,561,154,M,1,WHITE,C180,"Adenocarcinoma, NOS",3,IIIB,9,26,3,T3,N1b,MX,M0,26-Sep-11,MLH1,Negative,Radiation,1st Line,,11-May-12,19-Jun-12,,External Beam,4500,,Dead,22-Mar-16,Unrelated to Disease,,
CR-033,57,10-Dec-55,25530,1-Sep-11,561,154,M,1,WHITE,C180,"Adenocarcinoma, NOS",3,IIIB,9,26,3,T3,N1b,MX,M0,26-Sep-11,PMS2,Negative,Chemotherapy,Adjuvant,Capecitabine                                                            ,17-Oct-11,17-Apr-12,,,,,Dead,22-Mar-16,Unrelated to Disease,,
CR-033,57,10-Dec-55,25530,1-Sep-11,561,154,M,1,WHITE,C180,"Adenocarcinoma, NOS",3,IIIB,9,26,3,T3,N1b,MX,M0,26-Sep-11,PMS2,Negative,Radiation,1st Line,,11-May-12,19-Jun-12,,External Beam,4500,,Dead,22-Mar-16,Unrelated to Disease,,
CR-033,57,10-Dec-55,25530,1-Sep-11,561,154,M,1,WHITE,C180,"Adenocarcinoma, NOS",3,IIIB,9,26,3,T3,N1b,MX,M0,26-Sep-11,MSH2,Negative,Chemotherapy,Adjuvant,Capecitabine                                                            ,17-Oct-11,17-Apr-12,,,,,Dead,22-Mar-16,Unrelated to Disease,,
CR-033,57,10-Dec-55,25530,1-Sep-11,561,154,M,1,WHITE,C180,"Adenocarcinoma, NOS",3,IIIB,9,26,3,T3,N1b,MX,M0,26-Sep-11,MSH2,Negative,Radiation,1st Line,,11-May-12,19-Jun-12,,External Beam,4500,,Dead,22-Mar-16,Unrelated to Disease,,
CR-033,57,10-Dec-55,25530,1-Sep-11,561,154,M,1,WHITE,C180,"Adenocarcinoma, NOS",3,IIIB,9,26,3,T3,N1b,MX,M0,26-Sep-11,MSH6,Negative,Chemotherapy,Adjuvant,Capecitabine                                                            ,17-Oct-11,17-Apr-12,,,,,Dead,22-Mar-16,Unrelated to Disease,,
CR-033,57,10-Dec-55,25530,1-Sep-11,561,154,M,1,WHITE,C180,"Adenocarcinoma, NOS",3,IIIB,9,26,3,T3,N1b,MX,M0,26-Sep-11,MSH6,Negative,Radiation,1st Line,,11-May-12,19-Jun-12,,External Beam,4500,,Dead,22-Mar-16,Unrelated to Disease,,
CR-034,33,12-Jan-79,25538,9-Jun-11,578,154,M,1,WHITE,C182,"Adenocarcinoma, NOS",3,IIIB,8,55,20,T3,N2b,MX,M0,3-Aug-11,MLH1,Negative,Chemotherapy,1st Line,,,,,,,Not recommended,Dead,18-Jul-12,Primary Cancer,12-Jun-12,Liver
CR-034,33,12-Jan-79,25538,9-Jun-11,578,154,M,1,WHITE,C182,"Adenocarcinoma, NOS",3,IIIB,8,55,20,T3,N2b,MX,M0,3-Aug-11,MLH1,Negative,Chemotherapy,Adjuvant,FOLFOX,19-Sep-11,28-Feb-12,,,,,Dead,18-Jul-12,Primary Cancer,12-Jun-12,Liver
CR-034,33,12-Jan-79,25538,9-Jun-11,578,154,M,1,WHITE,C182,"Adenocarcinoma, NOS",3,IIIB,8,55,20,T3,N2b,MX,M0,21-Jun-12,KRAS,Negative,Chemotherapy,1st Line,,,,,,,Not recommended,Dead,18-Jul-12,Primary Cancer,12-Jun-12,Liver
CR-034,33,12-Jan-79,25538,9-Jun-11,578,154,M,1,WHITE,C182,"Adenocarcinoma, NOS",3,IIIB,8,55,20,T3,N2b,MX,M0,21-Jun-12,KRAS,Negative,Chemotherapy,Adjuvant,FOLFOX,19-Sep-11,28-Feb-12,,,,,Dead,18-Jul-12,Primary Cancer,12-Jun-12,Liver
CR-034,33,12-Jan-79,25538,9-Jun-11,578,154,M,1,WHITE,C182,"Adenocarcinoma, NOS",3,IIIB,8,55,20,T3,N2b,MX,M0,3-Aug-11,MSH6,Negative,Chemotherapy,1st Line,,,,,,,Not recommended,Dead,18-Jul-12,Primary Cancer,12-Jun-12,Liver
CR-034,33,12-Jan-79,25538,9-Jun-11,578,154,M,1,WHITE,C182,"Adenocarcinoma, NOS",3,IIIB,8,55,20,T3,N2b,MX,M0,3-Aug-11,MSH6,Negative,Chemotherapy,Adjuvant,FOLFOX,19-Sep-11,28-Feb-12,,,,,Dead,18-Jul-12,Primary Cancer,12-Jun-12,Liver
CR-034,33,12-Jan-79,25538,9-Jun-11,578,154,M,1,WHITE,C182,"Adenocarcinoma, NOS",3,IIIB,8,55,20,T3,N2b,MX,M0,3-Aug-11,PMS2,Negative,Chemotherapy,1st Line,,,,,,,Not recommended,Dead,18-Jul-12,Primary Cancer,12-Jun-12,Liver
CR-034,33,12-Jan-79,25538,9-Jun-11,578,154,M,1,WHITE,C182,"Adenocarcinoma, NOS",3,IIIB,8,55,20,T3,N2b,MX,M0,3-Aug-11,PMS2,Negative,Chemotherapy,Adjuvant,FOLFOX,19-Sep-11,28-Feb-12,,,,,Dead,18-Jul-12,Primary Cancer,12-Jun-12,Liver
CR-035,59,10-Dec-55,25541,24-Jun-13,595,154,F,1,WHITE,C180,"Adenocarcinoma, NOS",2,IIIC,5,14,14,T4b,N2b,MX,M0,24-Jun-13,MLH1,Negative,Chemotherapy,Adjuvant,,,,,,,Patient expired prior to starting treatment,Dead,27-Jun-13,Complications of Treatment,,
CR-035,59,10-Dec-55,25541,24-Jun-13,595,154,F,1,WHITE,C180,"Adenocarcinoma, NOS",2,IIIC,5,14,14,T4b,N2b,MX,M0,24-Jun-13,PMS2,Negative,Chemotherapy,Adjuvant,,,,,,,Patient expired prior to starting treatment,Dead,27-Jun-13,Complications of Treatment,,
CR-035,59,10-Dec-55,25541,24-Jun-13,595,154,F,1,WHITE,C180,"Adenocarcinoma, NOS",2,IIIC,5,14,14,T4b,N2b,MX,M0,24-Jun-13,MSH6,Negative,Chemotherapy,Adjuvant,,,,,,,Patient expired prior to starting treatment,Dead,27-Jun-13,Complications of Treatment,,
CR-035,59,10-Dec-55,25541,24-Jun-13,595,154,F,1,WHITE,C180,"Adenocarcinoma, NOS",2,IIIC,5,14,14,T4b,N2b,MX,M0,24-Jun-13,MSH2,Negative,Chemotherapy,Adjuvant,,,,,,,Patient expired prior to starting treatment,Dead,27-Jun-13,Complications of Treatment,,
CR-036,59,10-Dec-55,25553,2-Sep-13,612,154,M,1,WHITE,C187,"Adenocarcinoma, NOS",3,IIIB,4,30,4,T3,N2a,MX,M0,2-Sep-13,MSH2,Negative,Chemotherapy,Adjuvant,,,,,,,Not recommended,Dead,13-Apr-14,Unknown cause and unknown Disease Status,,
CR-036,59,10-Dec-55,25553,2-Sep-13,612,154,M,1,WHITE,C187,"Adenocarcinoma, NOS",3,IIIB,4,30,4,T3,N2a,MX,M0,2-Sep-13,MLH1,Negative,Chemotherapy,Adjuvant,,,,,,,Not recommended,Dead,13-Apr-14,Unknown cause and unknown Disease Status,,
CR-036,59,10-Dec-55,25553,2-Sep-13,612,154,M,1,WHITE,C187,"Adenocarcinoma, NOS",3,IIIB,4,30,4,T3,N2a,MX,M0,2-Sep-13,PMS2,Negative,Chemotherapy,Adjuvant,,,,,,,Not recommended,Dead,13-Apr-14,Unknown cause and unknown Disease Status,,
CR-036,59,10-Dec-55,25553,2-Sep-13,612,154,M,1,WHITE,C187,"Adenocarcinoma, NOS",3,IIIB,4,30,4,T3,N2a,MX,M0,2-Sep-13,MSH6,Negative,Chemotherapy,Adjuvant,,,,,,,Not recommended,Dead,13-Apr-14,Unknown cause and unknown Disease Status,,
CR-037 ,80,4-Oct-33,25554,4-Dec-12,629,154,F,1,WHITE,C186,"Adenocarcinoma, NOS",3,IIIB,3,11,5,T3,N2a,MX,M0,4-Dec-12,MSH2,Negative,Chemotherapy,Adjuvant,,,,,,,Not recommended,Dead,16-Feb-15,Unknown cause and unknown Disease Status,,
CR-037 ,80,4-Oct-33,25554,4-Dec-12,629,154,F,1,WHITE,C186,"Adenocarcinoma, NOS",3,IIIB,3,11,5,T3,N2a,MX,M0,4-Dec-12,MLH1,Negative,Chemotherapy,Adjuvant,,,,,,,Not recommended,Dead,16-Feb-15,Unknown cause and unknown Disease Status,,
CR-037 ,80,4-Oct-33,25554,4-Dec-12,629,154,F,1,WHITE,C186,"Adenocarcinoma, NOS",3,IIIB,3,11,5,T3,N2a,MX,M0,4-Dec-12,MSH6,Negative,Chemotherapy,Adjuvant,,,,,,,Not recommended,Dead,16-Feb-15,Unknown cause and unknown Disease Status,,
CR-037 ,80,4-Oct-33,25554,4-Dec-12,629,154,F,1,WHITE,C186,"Adenocarcinoma, NOS",3,IIIB,3,11,5,T3,N2a,MX,M0,4-Dec-12,PMS2,Negative,Chemotherapy,Adjuvant,,,,,,,Not recommended,Dead,16-Feb-15,Unknown cause and unknown Disease Status,,
CR-038,60,26-Jul-47,25555,1-Dec-06,646,124,M,1,WHITE,C182,"Adenocarcinoma, NOS",2,IIIB,5,25,2,T3,N1,MX,M0,,,,Chemotherapy,Adjuvant,Capecitabine                                                            ,25-Apr-07,25-Apr-07,,,,,Dead,17-Sep-13,Unrelated to Disease,,
CR-038,60,26-Jul-47,25555,1-Dec-06,646,124,M,1,WHITE,C182,"Adenocarcinoma, NOS",2,IIIB,5,25,2,T3,N1,MX,M0,,,,Chemotherapy,Adjuvant,Oxaliplatin                                                             ,25-Apr-07,25-Apr-07,,,,,Dead,17-Sep-13,Unrelated to Disease,,
CR-038,60,26-Jul-47,25555,1-Dec-06,646,124,M,1,WHITE,C182,"Adenocarcinoma, NOS",2,IIIB,5,25,2,T3,N1,MX,M0,,,,Chemotherapy,Adjuvant,FOLFOX,7-Feb-07,4-Apr-07,,,,,Dead,17-Sep-13,Unrelated to Disease,,
CR-039,62,27-May-48,25592,31-Mar-09,663,154,F,1,WHITE,C182,"Adenocarcinoma, NOS",2,IIIB,4,27,4,T3,N2,MX,M0,3-Jan-11,KRAS,Positive,Radiation,1st Line,,12-Apr-11,18-Apr-11,09-Jun-11,External Beam,2000,,Dead,13-Jun-11,Primary Cancer,25-Oct-10,Lung
CR-039,62,27-May-48,25592,31-Mar-09,663,154,F,1,WHITE,C182,"Adenocarcinoma, NOS",2,IIIB,4,27,4,T3,N2,MX,M0,3-Jan-11,KRAS,Positive,Chemotherapy,1st Line,FOLFIRI,25-Apr-11,6-Jun-11,,,,,Dead,13-Jun-11,Primary Cancer,25-Oct-10,Lung
CR-039,62,27-May-48,25592,31-Mar-09,663,154,F,1,WHITE,C182,"Adenocarcinoma, NOS",2,IIIB,4,27,4,T3,N2,MX,M0,3-Jan-11,KRAS,Positive,Chemotherapy,Adjuvant,FOLFOX,9-Jun-09,27-Oct-09,,,,,Dead,13-Jun-11,Primary Cancer,25-Oct-10,Lung
CR-040,52,24-Jun-54,25591,4-Sep-05,680,124,F,4,AMERICAN INDIAN OR ALASKA NATIVE,C182,"Adenocarcinoma, NOS",2,IIIB,9,22,9,T3,N2,MX,M0,,,,Radiation,1st Line,,2-Dec-08,8-Jan-09,,External Beam,3750,,Dead,16-Mar-09,Unknown cause but with Disease,10-Nov-08,Bone
CR-040,52,24-Jun-54,25591,4-Sep-05,680,124,F,4,AMERICAN INDIAN OR ALASKA NATIVE,C182,"Adenocarcinoma, NOS",2,IIIB,9,22,9,T3,N2,MX,M0,,,,Chemotherapy,Adjuvant,,,,,,,"Received treatment out of system, no information available",Dead,16-Mar-09,Unknown cause but with Disease,10-Nov-08,Bone
CR-041,50,14-Jul-60,25607,20-Jan-09,697,154,M,1,WHITE,C186,"Adenocarcinoma, NOS",3,IIIC,6,24,13,T3,N2b,MX,M0,21-Mar-11,KRAS,Negative,Radiation,1st Line,,19-Jul-11,22-Jul-11,,External Beam,1600,,Dead,6-Oct-11,Primary Cancer,15-Jul-11,Liver
CR-041,50,14-Jul-60,25607,20-Jan-09,697,154,M,1,WHITE,C186,"Adenocarcinoma, NOS",3,IIIC,6,24,13,T3,N2b,MX,M0,21-Mar-11,KRAS,Negative,Chemotherapy,Adjuvant,FOLFOX,3-Mar-09,6-Apr-09,,,,,Dead,6-Oct-11,Primary Cancer,15-Jul-11,Liver
CR-042,68,20-Feb-44,25613,3-Nov-11,714,154,M,7,UNKNOWN/UNAVAILABLE,C182,"Adenocarcinoma, NOS",1,IIIB,3,16,1,T3,N1,MX,M0,3-Nov-11,MSH6,Negative,Chemotherapy,Adjuvant,,,,,,,Patient expired prior to starting treatment,Dead,30-Nov-11,Unrelated to Disease,,
CR-042,68,20-Feb-44,25613,3-Nov-11,714,154,M,7,UNKNOWN/UNAVAILABLE,C182,"Adenocarcinoma, NOS",1,IIIB,3,16,1,T3,N1,MX,M0,3-Nov-11,MLH1,Negative,Chemotherapy,Adjuvant,,,,,,,Patient expired prior to starting treatment,Dead,30-Nov-11,Unrelated to Disease,,
CR-042,68,20-Feb-44,25613,3-Nov-11,714,154,M,7,UNKNOWN/UNAVAILABLE,C182,"Adenocarcinoma, NOS",1,IIIB,3,16,1,T3,N1,MX,M0,3-Nov-11,PMS2,Negative,Chemotherapy,Adjuvant,,,,02-Aug-12,,,Patient expired prior to starting treatment,Dead,30-Nov-11,Unrelated to Disease,,
CR-043,62,26-Aug-49,25617,7-Sep-10,731,154,M,1,WHITE,C186,"Adenocarcinoma, NOS",2,IIIB,6,21,3,T3,N1b,MX,M0,7-Sep-10,MLH1,Negative,Chemotherapy,1st Line,Oxaliplatin                                                             ,,2-Aug-12,02-Aug-12,,,"Received treatment out of system, no information available",Dead,4-Jun-13,Primary Cancer,7-Mar-12,Liver
CR-043,62,26-Aug-49,25617,7-Sep-10,731,154,M,1,WHITE,C186,"Adenocarcinoma, NOS",2,IIIB,6,21,3,T3,N1b,MX,M0,7-Sep-10,MLH1,Negative,Chemotherapy,1st Line,Capecitabine                                                            ,,2-Aug-12,02-Aug-12,,,"Received treatment out of system, no information available",Dead,4-Jun-13,Primary Cancer,7-Mar-12,Liver
CR-043,62,26-Aug-49,25617,7-Sep-10,731,154,M,1,WHITE,C186,"Adenocarcinoma, NOS",2,IIIB,6,21,3,T3,N1b,MX,M0,3-Aug-12,KRAS,Negative,Chemotherapy,1st Line,Oxaliplatin                                                             ,,2-Aug-12,,,,"Received treatment out of system, no information available",Dead,4-Jun-13,Primary Cancer,7-Mar-12,Liver
CR-043,62,26-Aug-49,25617,7-Sep-10,731,154,M,1,WHITE,C186,"Adenocarcinoma, NOS",2,IIIB,6,21,3,T3,N1b,MX,M0,3-Aug-12,KRAS,Negative,Chemotherapy,1st Line,Capecitabine                                                            ,,2-Aug-12,,,,"Received treatment out of system, no information available",Dead,4-Jun-13,Primary Cancer,7-Mar-12,Liver
CR-043,62,26-Aug-49,25617,7-Sep-10,731,154,M,1,WHITE,C186,"Adenocarcinoma, NOS",2,IIIB,6,21,3,T3,N1b,MX,M0,7-Sep-10,MSH6,Negative,Chemotherapy,1st Line,Oxaliplatin                                                             ,,2-Aug-12,,,,"Received treatment out of system, no information available",Dead,4-Jun-13,Primary Cancer,7-Mar-12,Liver
CR-043,62,26-Aug-49,25617,7-Sep-10,731,154,M,1,WHITE,C186,"Adenocarcinoma, NOS",2,IIIB,6,21,3,T3,N1b,MX,M0,7-Sep-10,MSH6,Negative,Chemotherapy,1st Line,Capecitabine                                                            ,,2-Aug-12,,,,"Received treatment out of system, no information available",Dead,4-Jun-13,Primary Cancer,7-Mar-12,Liver
CR-043,62,26-Aug-49,25617,7-Sep-10,731,154,M,1,WHITE,C186,"Adenocarcinoma, NOS",2,IIIB,6,21,3,T3,N1b,MX,M0,7-Sep-10,PMS2,Negative,Chemotherapy,1st Line,Oxaliplatin                                                             ,,2-Aug-12,,,,"Received treatment out of system, no information available",Dead,4-Jun-13,Primary Cancer,7-Mar-12,Liver
CR-043,62,26-Aug-49,25617,7-Sep-10,731,154,M,1,WHITE,C186,"Adenocarcinoma, NOS",2,IIIB,6,21,3,T3,N1b,MX,M0,7-Sep-10,PMS2,Negative,Chemotherapy,1st Line,Capecitabine                                                            ,,2-Aug-12,,,,"Received treatment out of system, no information available",Dead,4-Jun-13,Primary Cancer,7-Mar-12,Liver
CR-043,62,26-Aug-49,25617,7-Sep-10,731,154,M,1,WHITE,C186,"Adenocarcinoma, NOS",2,IIIB,6,21,3,T3,N1b,MX,M0,7-Sep-10,MLH1,Negative,Chemotherapy,2nd Line,Cetuximab                                                               ,20-Aug-12,,,,,"Received treatment out of system, no information available",Dead,4-Jun-13,Primary Cancer,7-Mar-12,Liver
CR-043,62,26-Aug-49,25617,7-Sep-10,731,154,M,1,WHITE,C186,"Adenocarcinoma, NOS",2,IIIB,6,21,3,T3,N1b,MX,M0,7-Sep-10,MLH1,Negative,Chemotherapy,2nd Line,Irinotecan Hydrochloride                                                ,10-Nov-12,,,,,"Received treatment out of system, no information available",Dead,4-Jun-13,Primary Cancer,7-Mar-12,Liver
CR-043,62,26-Aug-49,25617,7-Sep-10,731,154,M,1,WHITE,C186,"Adenocarcinoma, NOS",2,IIIB,6,21,3,T3,N1b,MX,M0,3-Aug-12,KRAS,Negative,Chemotherapy,2nd Line,Cetuximab                                                               ,20-Aug-12,,,,,"Received treatment out of system, no information available",Dead,4-Jun-13,Primary Cancer,7-Mar-12,Liver
CR-043,62,26-Aug-49,25617,7-Sep-10,731,154,M,1,WHITE,C186,"Adenocarcinoma, NOS",2,IIIB,6,21,3,T3,N1b,MX,M0,3-Aug-12,KRAS,Negative,Chemotherapy,2nd Line,Irinotecan Hydrochloride                                                ,10-Nov-12,,,,,"Received treatment out of system, no information available",Dead,4-Jun-13,Primary Cancer,7-Mar-12,Liver
CR-043,62,26-Aug-49,25617,7-Sep-10,731,154,M,1,WHITE,C186,"Adenocarcinoma, NOS",2,IIIB,6,21,3,T3,N1b,MX,M0,7-Sep-10,MSH6,Negative,Chemotherapy,2nd Line,Cetuximab                                                               ,20-Aug-12,,,,,"Received treatment out of system, no information available",Dead,4-Jun-13,Primary Cancer,7-Mar-12,Liver
CR-043,62,26-Aug-49,25617,7-Sep-10,731,154,M,1,WHITE,C186,"Adenocarcinoma, NOS",2,IIIB,6,21,3,T3,N1b,MX,M0,7-Sep-10,MSH6,Negative,Chemotherapy,2nd Line,Irinotecan Hydrochloride                                                ,10-Nov-12,,,,,"Received treatment out of system, no information available",Dead,4-Jun-13,Primary Cancer,7-Mar-12,Liver
CR-043,62,26-Aug-49,25617,7-Sep-10,731,154,M,1,WHITE,C186,"Adenocarcinoma, NOS",2,IIIB,6,21,3,T3,N1b,MX,M0,7-Sep-10,PMS2,Negative,Chemotherapy,2nd Line,Cetuximab                                                               ,20-Aug-12,,,,,"Received treatment out of system, no information available",Dead,4-Jun-13,Primary Cancer,7-Mar-12,Liver
CR-043,62,26-Aug-49,25617,7-Sep-10,731,154,M,1,WHITE,C186,"Adenocarcinoma, NOS",2,IIIB,6,21,3,T3,N1b,MX,M0,7-Sep-10,PMS2,Negative,Chemotherapy,2nd Line,Irinotecan Hydrochloride                                                ,10-Nov-12,,,,,"Received treatment out of system, no information available",Dead,4-Jun-13,Primary Cancer,7-Mar-12,Liver
CR-043,62,26-Aug-49,25617,7-Sep-10,731,154,M,1,WHITE,C186,"Adenocarcinoma, NOS",2,IIIB,6,21,3,T3,N1b,MX,M0,7-Sep-10,MLH1,Negative,Chemotherapy,Adjuvant,,,,,,,"Received treatment out of system, no information available",Dead,4-Jun-13,Primary Cancer,7-Mar-12,Liver
CR-043,62,26-Aug-49,25617,7-Sep-10,731,154,M,1,WHITE,C186,"Adenocarcinoma, NOS",2,IIIB,6,21,3,T3,N1b,MX,M0,7-Sep-10,MLH1,Negative,Radiation,,,17-May-11,21-Jun-11,,External Beam,4500,,Dead,4-Jun-13,Primary Cancer,7-Mar-12,Liver
CR-043,62,26-Aug-49,25617,7-Sep-10,731,154,M,1,WHITE,C186,"Adenocarcinoma, NOS",2,IIIB,6,21,3,T3,N1b,MX,M0,3-Aug-12,KRAS,Negative,Chemotherapy,Adjuvant,,,,,,,"Received treatment out of system, no information available",Dead,4-Jun-13,Primary Cancer,7-Mar-12,Liver
CR-043,62,26-Aug-49,25617,7-Sep-10,731,154,M,1,WHITE,C186,"Adenocarcinoma, NOS",2,IIIB,6,21,3,T3,N1b,MX,M0,3-Aug-12,KRAS,Negative,Radiation,,,17-May-11,21-Jun-11,,External Beam,4500,,Dead,4-Jun-13,Primary Cancer,7-Mar-12,Liver
CR-043,62,26-Aug-49,25617,7-Sep-10,731,154,M,1,WHITE,C186,"Adenocarcinoma, NOS",2,IIIB,6,21,3,T3,N1b,MX,M0,7-Sep-10,MSH6,Negative,Chemotherapy,Adjuvant,,,,,,,"Received treatment out of system, no information available",Dead,4-Jun-13,Primary Cancer,7-Mar-12,Liver
CR-043,62,26-Aug-49,25617,7-Sep-10,731,154,M,1,WHITE,C186,"Adenocarcinoma, NOS",2,IIIB,6,21,3,T3,N1b,MX,M0,7-Sep-10,MSH6,Negative,Radiation,,,17-May-11,21-Jun-11,,External Beam,4500,,Dead,4-Jun-13,Primary Cancer,7-Mar-12,Liver
CR-043,62,26-Aug-49,25617,7-Sep-10,731,154,M,1,WHITE,C186,"Adenocarcinoma, NOS",2,IIIB,6,21,3,T3,N1b,MX,M0,7-Sep-10,PMS2,Negative,Chemotherapy,Adjuvant,,,,,,,"Received treatment out of system, no information available",Dead,4-Jun-13,Primary Cancer,7-Mar-12,Liver
CR-043,62,26-Aug-49,25617,7-Sep-10,731,154,M,1,WHITE,C186,"Adenocarcinoma, NOS",2,IIIB,6,21,3,T3,N1b,MX,M0,7-Sep-10,PMS2,Negative,Radiation,,,17-May-11,21-Jun-11,,External Beam,4500,,Dead,4-Jun-13,Primary Cancer,7-Mar-12,Liver
CR-044,82,31-Aug-33,25663,22-Jan-14,748,128,F,1,WHITE,C180,"Adenocarcinoma, NOS",2,IIIB,4,13,2,T3,N1b,MX,M0,31-Jan-14,MLH1,Negative,Chemotherapy,Adjuvant,,,,,,,Not recommended due to age/co-morbidities,Dead,23-Jan-15,,,
CR-044,82,31-Aug-33,25663,22-Jan-14,748,128,F,1,WHITE,C180,"Adenocarcinoma, NOS",2,IIIB,4,13,2,T3,N1b,MX,M0,31-Jan-14,MSH2,Negative,Chemotherapy,Adjuvant,,,,,,,Not recommended due to age/co-morbidities,Dead,23-Jan-15,,,
CR-044,82,31-Aug-33,25663,22-Jan-14,748,128,F,1,WHITE,C180,"Adenocarcinoma, NOS",2,IIIB,4,13,2,T3,N1b,MX,M0,31-Jan-14,MSH6,Negative,Chemotherapy,Adjuvant,,,,,,,Not recommended due to age/co-morbidities,Dead,23-Jan-15,,,
CR-044,82,31-Aug-33,25663,22-Jan-14,748,128,F,1,WHITE,C180,"Adenocarcinoma, NOS",2,IIIB,4,13,2,T3,N1b,MX,M0,31-Jan-14,PMS2,Negative,Chemotherapy,Adjuvant,,,,,,,Not recommended due to age/co-morbidities,Dead,23-Jan-15,,,
CR-045,76,31-Aug-33,25664,30-Dec-08,765,154,F,1,WHITE,C180,"Adenocarcinoma, NOS",3,IIIC,9,7,5,T4,N2,,M0,,,,Chemotherapy,Adjuvant,Fluorouracil                                                            ,19-Feb-09,19-Mar-09,,,,,Dead,23-Mar-09,,,
CR-045,76,31-Aug-33,25664,30-Dec-08,765,154,F,1,WHITE,C180,"Adenocarcinoma, NOS",3,IIIC,9,7,5,T4,N2,,M0,,,,Radiation,,,19-Feb-09,18-Mar-09,,External Beam,3420,,Dead,23-Mar-09,,,
CR-046,14,7-Apr-92,25665,17-Feb-05,782,128,M,1,WHITE,C180,Signet ring cell carcinoma,3,IIIB,7,10,1,T4,N1,MX,M0,,,,Radiation,,,,,,,,Contra-Indication age related,Dead,22-Jun-09,Unknown cause and unknown Disease Status,,
CR-046,14,7-Apr-92,25665,17-Feb-05,782,128,M,1,WHITE,C180,Signet ring cell carcinoma,3,IIIB,7,10,1,T4,N1,MX,M0,,,,Chemotherapy,Adjuvant,,,,,,,Not recommended due to age/co-morbidities,Dead,22-Jun-09,Unknown cause and unknown Disease Status,,
CR-047,32,12-Jun-76,25667,24-Oct-07,799,128,F,1,WHITE,C180,"Adenocarcinoma, NOS",2,IIIB,4,14,2,T4b,N1,,M0,,,,Chemotherapy,Adjuvant,,,,,,,Not recommended due to age/co-morbidities,Dead,26-Dec-07,Unrelated to Disease,,
CR-048,42,16-Jun-65,25670,3-Feb-06,816,126,F,1,WHITE,C184,"Adenocarcinoma, NOS",2,IIIB,5,13,1,T3,N1,,M0,,,,Chemotherapy,Adjuvant,Capecitabine                                                            ,1-Apr-06,1-Oct-06,,,,,Dead,4-May-11,Unrelated to Disease,,
CR-049,43,16-Jun-65,25674,2-Feb-07,833,128,F,1,WHITE,C187,"Adenocarcinoma, NOS",2,IIIB,2,2,15,T4a,N1,,M0,,,,Chemotherapy,Adjuvant,,,,,,,Patient choice,Dead,29-Aug-09,Unknown cause and unknown Disease Status,,
CR-050,21,3-Feb-87,25675,18-Jan-07,850,116,M,1,WHITE,C187,"Adenocarcinoma, NOS",2,IIIB,6,15,2,T3,N1,,M0,,,,Chemotherapy,Adjuvant,,,,,,,Not recommended due to age/co-morbidities,Dead,13-Nov-07,Unknown cause and unknown Disease Status,,
CR-051,54,2-Nov-55,25685,29-Aug-08,867,132,F,1,WHITE,C182,"Adenocarcinoma, NOS",3,IIIC,7,14,5,T4b,N2,,M0,,,,Chemotherapy,Adjuvant,,,,,,,Not recommended due to age/co-morbidities,Dead,28-May-09,Unknown cause but with Disease,16-Dec-08,Soft Tissue
CR-052,69,3-Nov-44,25686,26-Sep-12,884,132,F,1,WHITE,C180,"Adenocarcinoma, NOS",2,IIIB,3,14,3,T3,N1b,MX,M0,8-Oct-12,MLH1,Negative,Chemotherapy,1st Line,Bevacizumab                                                             ,3-Dec-13,28-Jul-14,04-Mar-14,,,,Dead,13-Oct-14,Primary Cancer,20-Nov-13,Liver
CR-052,69,3-Nov-44,25686,26-Sep-12,884,132,F,1,WHITE,C180,"Adenocarcinoma, NOS",2,IIIB,3,14,3,T3,N1b,MX,M0,8-Oct-12,MLH1,Negative,Chemotherapy,1st Line,FOLFIRI,3-Dec-13,28-Jul-14,04-Mar-14,,,,Dead,13-Oct-14,Primary Cancer,20-Nov-13,Liver
CR-052,69,3-Nov-44,25686,26-Sep-12,884,132,F,1,WHITE,C180,"Adenocarcinoma, NOS",2,IIIB,3,14,3,T3,N1b,MX,M0,8-Oct-12,MSH2,Negative,Chemotherapy,1st Line,Bevacizumab                                                             ,3-Dec-13,28-Jul-14,,,,,Dead,13-Oct-14,Primary Cancer,20-Nov-13,Liver
CR-052,69,3-Nov-44,25686,26-Sep-12,884,132,F,1,WHITE,C180,"Adenocarcinoma, NOS",2,IIIB,3,14,3,T3,N1b,MX,M0,8-Oct-12,MSH2,Negative,Chemotherapy,1st Line,FOLFIRI,3-Dec-13,28-Jul-14,,,,,Dead,13-Oct-14,Primary Cancer,20-Nov-13,Liver
CR-052,69,3-Nov-44,25686,26-Sep-12,884,132,F,1,WHITE,C180,"Adenocarcinoma, NOS",2,IIIB,3,14,3,T3,N1b,MX,M0,8-Oct-12,MSH6,Negative,Chemotherapy,1st Line,Bevacizumab                                                             ,3-Dec-13,28-Jul-14,,,,,Dead,13-Oct-14,Primary Cancer,20-Nov-13,Liver
CR-052,69,3-Nov-44,25686,26-Sep-12,884,132,F,1,WHITE,C180,"Adenocarcinoma, NOS",2,IIIB,3,14,3,T3,N1b,MX,M0,8-Oct-12,MSH6,Negative,Chemotherapy,1st Line,FOLFIRI,3-Dec-13,28-Jul-14,,,,,Dead,13-Oct-14,Primary Cancer,20-Nov-13,Liver
CR-052,69,3-Nov-44,25686,26-Sep-12,884,132,F,1,WHITE,C180,"Adenocarcinoma, NOS",2,IIIB,3,14,3,T3,N1b,MX,M0,8-Oct-12,MSH6,Negative,Chemotherapy,1st Line,Bevacizumab                                                             ,3-Dec-13,28-Jul-14,,,,,Dead,13-Oct-14,Primary Cancer,20-Nov-13,Liver
CR-052,69,3-Nov-44,25686,26-Sep-12,884,132,F,1,WHITE,C180,"Adenocarcinoma, NOS",2,IIIB,3,14,3,T3,N1b,MX,M0,8-Oct-12,MSH6,Negative,Chemotherapy,1st Line,FOLFIRI,3-Dec-13,28-Jul-14,,,,,Dead,13-Oct-14,Primary Cancer,20-Nov-13,Liver
CR-052,69,3-Nov-44,25686,26-Sep-12,884,132,F,1,WHITE,C180,"Adenocarcinoma, NOS",2,IIIB,3,14,3,T3,N1b,MX,M0,8-Oct-12,MLH1,Negative,Chemotherapy,Adjuvant,FOLFOX,3-Jan-13,1-May-13,,,,,Dead,13-Oct-14,Primary Cancer,20-Nov-13,Liver
CR-052,69,3-Nov-44,25686,26-Sep-12,884,132,F,1,WHITE,C180,"Adenocarcinoma, NOS",2,IIIB,3,14,3,T3,N1b,MX,M0,8-Oct-12,MSH2,Negative,Chemotherapy,Adjuvant,FOLFOX,3-Jan-13,1-May-13,,,,,Dead,13-Oct-14,Primary Cancer,20-Nov-13,Liver
CR-052,69,3-Nov-44,25686,26-Sep-12,884,132,F,1,WHITE,C180,"Adenocarcinoma, NOS",2,IIIB,3,14,3,T3,N1b,MX,M0,8-Oct-12,MSH6,Negative,Chemotherapy,Adjuvant,FOLFOX,3-Jan-13,1-May-13,,,,,Dead,13-Oct-14,Primary Cancer,20-Nov-13,Liver
CR-052,69,3-Nov-44,25686,26-Sep-12,884,132,F,1,WHITE,C180,"Adenocarcinoma, NOS",2,IIIB,3,14,3,T3,N1b,MX,M0,8-Oct-12,MSH6,Negative,Chemotherapy,Adjuvant,FOLFOX,3-Jan-13,1-May-13,,,,,Dead,13-Oct-14,Primary Cancer,20-Nov-13,Liver
CR-053,74,13-Jan-37,25687,26-May-10,901,154,F,1,WHITE,C182,"Adenocarcinoma, NOS",2,IIIB,5,32,2,T4a,N1b,,M0,26-May-10,MSH6,Negative,Chemotherapy,1st Line,Fluorouracil                                                            ,14-Aug-12,9-Oct-12,08-Oct-14,,,,Dead,24-Oct-12,Complications of Treatment,26-Jun-12,Lung
CR-053,74,13-Jan-37,25687,26-May-10,901,154,F,1,WHITE,C182,"Adenocarcinoma, NOS",2,IIIB,5,32,2,T4a,N1b,,M0,26-May-10,PMS2,Negative,Chemotherapy,1st Line,Fluorouracil                                                            ,14-Aug-12,9-Oct-12,,,,,Dead,24-Oct-12,Complications of Treatment,26-Jun-12,Lung
CR-053,74,13-Jan-37,25687,26-May-10,901,154,F,1,WHITE,C182,"Adenocarcinoma, NOS",2,IIIB,5,32,2,T4a,N1b,,M0,26-May-10,MSH2,Negative,Chemotherapy,1st Line,Fluorouracil                                                            ,14-Aug-12,9-Oct-12,,,,,Dead,24-Oct-12,Complications of Treatment,26-Jun-12,Lung
CR-053,74,13-Jan-37,25687,26-May-10,901,154,F,1,WHITE,C182,"Adenocarcinoma, NOS",2,IIIB,5,32,2,T4a,N1b,,M0,26-May-10,MLH1,Negative,Chemotherapy,1st Line,Fluorouracil                                                            ,14-Aug-12,9-Oct-12,,,,,Dead,24-Oct-12,Complications of Treatment,26-Jun-12,Lung
CR-053,74,13-Jan-37,25687,26-May-10,901,154,F,1,WHITE,C182,"Adenocarcinoma, NOS",2,IIIB,5,32,2,T4a,N1b,,M0,26-May-10,MSH6,Negative,Chemotherapy,Adjuvant,Fluorouracil                                                            ,15-Jul-10,15-Dec-10,,,,,Dead,24-Oct-12,Complications of Treatment,26-Jun-12,Lung
CR-053,74,13-Jan-37,25687,26-May-10,901,154,F,1,WHITE,C182,"Adenocarcinoma, NOS",2,IIIB,5,32,2,T4a,N1b,,M0,26-May-10,PMS2,Negative,Chemotherapy,Adjuvant,Fluorouracil                                                            ,15-Jul-10,15-Dec-10,,,,,Dead,24-Oct-12,Complications of Treatment,26-Jun-12,Lung
CR-053,74,13-Jan-37,25687,26-May-10,901,154,F,1,WHITE,C182,"Adenocarcinoma, NOS",2,IIIB,5,32,2,T4a,N1b,,M0,26-May-10,MSH2,Negative,Chemotherapy,Adjuvant,Fluorouracil                                                            ,15-Jul-10,15-Dec-10,,,,,Dead,24-Oct-12,Complications of Treatment,26-Jun-12,Lung
CR-053,74,13-Jan-37,25687,26-May-10,901,154,F,1,WHITE,C182,"Adenocarcinoma, NOS",2,IIIB,5,32,2,T4a,N1b,,M0,26-May-10,MLH1,Negative,Chemotherapy,Adjuvant,Fluorouracil                                                            ,15-Jul-10,15-Dec-10,,,,,Dead,24-Oct-12,Complications of Treatment,26-Jun-12,Lung
CR-054,29,24-Sep-81,25688,16-Nov-09,918,132,M,1,WHITE,C186,"Adenocarcinoma, NOS",3,IIIC,3,8,5,T4a,N2a,,M0,16-Nov-09,MSH2,Negative,Chemotherapy,1st Line,Bevacizumab                                                             ,,,08-Oct-14,,,,Dead,19-Nov-14,Primary Cancer,10-Jan-13,Soft Tissue
CR-054,29,24-Sep-81,25688,16-Nov-09,918,132,M,1,WHITE,C186,"Adenocarcinoma, NOS",3,IIIC,3,8,5,T4a,N2a,,M0,16-Nov-09,MSH2,Negative,Chemotherapy,1st Line,Fluorouracil                                                            ,,,,,,,Dead,19-Nov-14,Primary Cancer,10-Jan-13,Soft Tissue
CR-054,29,24-Sep-81,25688,16-Nov-09,918,132,M,1,WHITE,C186,"Adenocarcinoma, NOS",3,IIIC,3,8,5,T4a,N2a,,M0,16-Nov-09,MLH1,Negative,Chemotherapy,1st Line,Bevacizumab                                                             ,,,,,,,Dead,19-Nov-14,Primary Cancer,10-Jan-13,Soft Tissue
CR-054,29,24-Sep-81,25688,16-Nov-09,918,132,M,1,WHITE,C186,"Adenocarcinoma, NOS",3,IIIC,3,8,5,T4a,N2a,,M0,16-Nov-09,MLH1,Negative,Chemotherapy,1st Line,Fluorouracil                                                            ,,,,,,,Dead,19-Nov-14,Primary Cancer,10-Jan-13,Soft Tissue
CR-054,29,24-Sep-81,25688,16-Nov-09,918,132,M,1,WHITE,C186,"Adenocarcinoma, NOS",3,IIIC,3,8,5,T4a,N2a,,M0,16-Nov-09,MSH6,Negative,Chemotherapy,1st Line,Bevacizumab                                                             ,,,,,,,Dead,19-Nov-14,Primary Cancer,10-Jan-13,Soft Tissue
CR-054,29,24-Sep-81,25688,16-Nov-09,918,132,M,1,WHITE,C186,"Adenocarcinoma, NOS",3,IIIC,3,8,5,T4a,N2a,,M0,16-Nov-09,MSH6,Negative,Chemotherapy,1st Line,Fluorouracil                                                            ,,,,,,,Dead,19-Nov-14,Primary Cancer,10-Jan-13,Soft Tissue
CR-054,29,24-Sep-81,25688,16-Nov-09,918,132,M,1,WHITE,C186,"Adenocarcinoma, NOS",3,IIIC,3,8,5,T4a,N2a,,M0,16-Nov-09,PMS2,Negative,Chemotherapy,1st Line,Bevacizumab                                                             ,,,,,,,Dead,19-Nov-14,Primary Cancer,10-Jan-13,Soft Tissue
CR-054,29,24-Sep-81,25688,16-Nov-09,918,132,M,1,WHITE,C186,"Adenocarcinoma, NOS",3,IIIC,3,8,5,T4a,N2a,,M0,16-Nov-09,PMS2,Negative,Chemotherapy,1st Line,Fluorouracil                                                            ,,,,,,,Dead,19-Nov-14,Primary Cancer,10-Jan-13,Soft Tissue
CR-054,29,24-Sep-81,25688,16-Nov-09,918,132,M,1,WHITE,C186,"Adenocarcinoma, NOS",3,IIIC,3,8,5,T4a,N2a,,M0,16-Nov-09,MSH2,Negative,Chemotherapy,Adjuvant,FOLFOX,28-Dec-09,1-Jun-10,,,,,Dead,19-Nov-14,Primary Cancer,10-Jan-13,Soft Tissue
CR-054,29,24-Sep-81,25688,16-Nov-09,918,132,M,1,WHITE,C186,"Adenocarcinoma, NOS",3,IIIC,3,8,5,T4a,N2a,,M0,16-Nov-09,MLH1,Negative,Chemotherapy,Adjuvant,FOLFOX,28-Dec-09,1-Jun-10,,,,,Dead,19-Nov-14,Primary Cancer,10-Jan-13,Soft Tissue
CR-054,29,24-Sep-81,25688,16-Nov-09,918,132,M,1,WHITE,C186,"Adenocarcinoma, NOS",3,IIIC,3,8,5,T4a,N2a,,M0,16-Nov-09,MSH6,Negative,Chemotherapy,Adjuvant,FOLFOX,28-Dec-09,1-Jun-10,,,,,Dead,19-Nov-14,Primary Cancer,10-Jan-13,Soft Tissue
CR-054,29,24-Sep-81,25688,16-Nov-09,918,132,M,1,WHITE,C186,"Adenocarcinoma, NOS",3,IIIC,3,8,5,T4a,N2a,,M0,16-Nov-09,PMS2,Negative,Chemotherapy,Adjuvant,FOLFOX,28-Dec-09,1-Jun-10,,,,,Dead,19-Nov-14,Primary Cancer,10-Jan-13,Soft Tissue
CR-055,42,10-Jan-64,25689,22-Jul-05,935,132,M,5,HISPANIC,C182,"Adenocarcinoma, NOS",2,IIIB,8,19,4,T3,N2,,M0,,,,Chemotherapy,Adjuvant,,,,,,,"Received treatment out of system, no information available",Dead,4-Jul-11,Unknown cause and unknown Disease Status,,
CR-056,18,31-Dec-96,25690,18-Feb-13,952,132,F,1,WHITE,C180,"Adenocarcinoma, NOS",3,IIIB,6,21,3,T3,N1b,MX,M0,18-Feb-13,BRAF,Positive,Chemotherapy,Adjuvant,,,,,,,Not recommended due to age/co-morbidities,Dead,16-Aug-13,Unrelated to Cancer but with Disease,2-Aug-13,Soft Tissue
CR-056,18,31-Dec-96,25690,18-Feb-13,952,132,F,1,WHITE,C180,"Adenocarcinoma, NOS",3,IIIB,6,21,3,T3,N1b,MX,M0,18-Feb-13,BRAF,Positive,Chemotherapy,1st Line,,,,,,,Not recommended due to age/co-morbidities,Dead,16-Aug-13,Unrelated to Cancer but with Disease,2-Aug-13,Soft Tissue
CR-056,18,31-Dec-96,25690,18-Feb-13,952,132,F,1,WHITE,C180,"Adenocarcinoma, NOS",3,IIIB,6,21,3,T3,N1b,MX,M0,18-Feb-13,MSH2,Negative,Chemotherapy,Adjuvant,,,,,,,Not recommended due to age/co-morbidities,Dead,16-Aug-13,Unrelated to Cancer but with Disease,2-Aug-13,Soft Tissue
CR-056,18,31-Dec-96,25690,18-Feb-13,952,132,F,1,WHITE,C180,"Adenocarcinoma, NOS",3,IIIB,6,21,3,T3,N1b,MX,M0,18-Feb-13,MSH2,Negative,Chemotherapy,1st Line,,,,,,,Not recommended due to age/co-morbidities,Dead,16-Aug-13,Unrelated to Cancer but with Disease,2-Aug-13,Soft Tissue
CR-056,18,31-Dec-96,25690,18-Feb-13,952,132,F,1,WHITE,C180,"Adenocarcinoma, NOS",3,IIIB,6,21,3,T3,N1b,MX,M0,18-Feb-13,MSH6,Negative,Chemotherapy,Adjuvant,,,,,,,Not recommended due to age/co-morbidities,Dead,16-Aug-13,Unrelated to Cancer but with Disease,2-Aug-13,Soft Tissue
CR-056,18,31-Dec-96,25690,18-Feb-13,952,132,F,1,WHITE,C180,"Adenocarcinoma, NOS",3,IIIB,6,21,3,T3,N1b,MX,M0,18-Feb-13,MSH6,Negative,Chemotherapy,1st Line,,,,,,,Not recommended due to age/co-morbidities,Dead,16-Aug-13,Unrelated to Cancer but with Disease,2-Aug-13,Soft Tissue
CR-056,18,31-Dec-96,25690,18-Feb-13,952,132,F,1,WHITE,C180,"Adenocarcinoma, NOS",3,IIIB,6,21,3,T3,N1b,MX,M0,18-Feb-13,KRAS,Negative,Chemotherapy,Adjuvant,,,,,,,Not recommended due to age/co-morbidities,Dead,16-Aug-13,Unrelated to Cancer but with Disease,2-Aug-13,Soft Tissue
CR-056,18,31-Dec-96,25690,18-Feb-13,952,132,F,1,WHITE,C180,"Adenocarcinoma, NOS",3,IIIB,6,21,3,T3,N1b,MX,M0,18-Feb-13,KRAS,Negative,Chemotherapy,1st Line,,,,,,,Not recommended due to age/co-morbidities,Dead,16-Aug-13,Unrelated to Cancer but with Disease,2-Aug-13,Soft Tissue
CR-056,18,31-Dec-96,25690,18-Feb-13,952,132,F,1,WHITE,C180,"Adenocarcinoma, NOS",3,IIIB,6,21,3,T3,N1b,MX,M0,18-Feb-13,MLH1,Positive,Chemotherapy,Adjuvant,,,,,,,Not recommended due to age/co-morbidities,Dead,16-Aug-13,Unrelated to Cancer but with Disease,2-Aug-13,Soft Tissue
CR-056,18,31-Dec-96,25690,18-Feb-13,952,132,F,1,WHITE,C180,"Adenocarcinoma, NOS",3,IIIB,6,21,3,T3,N1b,MX,M0,18-Feb-13,MLH1,Positive,Chemotherapy,1st Line,,,,,,,Not recommended due to age/co-morbidities,Dead,16-Aug-13,Unrelated to Cancer but with Disease,2-Aug-13,Soft Tissue
CR-056,18,31-Dec-96,25690,18-Feb-13,952,132,F,1,WHITE,C180,"Adenocarcinoma, NOS",3,IIIB,6,21,3,T3,N1b,MX,M0,18-Feb-13,PMS2,Positive,Chemotherapy,Adjuvant,,,,,,,Not recommended due to age/co-morbidities,Dead,16-Aug-13,Unrelated to Cancer but with Disease,2-Aug-13,Soft Tissue
CR-056,18,31-Dec-96,25690,18-Feb-13,952,132,F,1,WHITE,C180,"Adenocarcinoma, NOS",3,IIIB,6,21,3,T3,N1b,MX,M0,18-Feb-13,PMS2,Positive,Chemotherapy,1st Line,,,,,,,Not recommended due to age/co-morbidities,Dead,16-Aug-13,Unrelated to Cancer but with Disease,2-Aug-13,Soft Tissue
CR-057,38,12-Apr-69,25693,1-Aug-06,969,132,M,1,WHITE,C180,"Adenocarcinoma, NOS",2,IIIC,11,23,8,T3,N2,,M0,,,,Chemotherapy,1st Line,FOLFOX,27-Feb-08,2-Apr-08,29-Apr-08,,,,Alive,,,29-Jun-07,Liver
CR-057,38,12-Apr-69,25693,1-Aug-06,969,132,M,1,WHITE,C180,"Adenocarcinoma, NOS",2,IIIC,11,23,8,T3,N2,,M0,,,,Chemotherapy,1st Line,Bevacizumab                                                             ,27-Feb-08,2-Apr-08,29-Apr-08,,,,Alive,,,29-Jun-07,Liver
CR-057,38,12-Apr-69,25693,1-Aug-06,969,132,M,1,WHITE,C180,"Adenocarcinoma, NOS",2,IIIC,11,23,8,T3,N2,,M0,,,,Radiation,2nd Line,,9-Apr-08,22-Apr-08,,External Beam,3000,,Alive,,,29-Jun-07,Liver
CR-057,38,12-Apr-69,25693,1-Aug-06,969,132,M,1,WHITE,C180,"Adenocarcinoma, NOS",2,IIIC,11,23,8,T3,N2,,M0,,,,Chemotherapy,Adjuvant,FOLFOX,6-Sep-06,5-Feb-07,,,,,Alive,,,29-Jun-07,Liver
CR-058,42,21-May-64,25704,7-Mar-05,986,132,M,1,WHITE,C187,Mucinous adenocarcinoma,2,IIIB,3,12,6,T3,N2,MX,M0,26-May-05,MSH2,Negative,Chemotherapy,Adjuvant,,,,,,,"Received treatment out of system, no information available",Dead,31-Aug-07,Unknown cause but with Disease,,
CR-058,42,21-May-64,25704,7-Mar-05,986,132,M,1,WHITE,C187,Mucinous adenocarcinoma,2,IIIB,3,12,6,T3,N2,MX,M0,26-May-05,MLH1,Negative,Chemotherapy,,,,,,,,"Received treatment out of system, no information available",Dead,31-Aug-07,Unknown cause but with Disease,,
CR-059,63,15-Apr-52,25705,13-Oct-14,1003,116,F,1,WHITE,C180,"Adenocarcinoma, NOS",2,IIIC,12,30,6,T4b,N2a,MX,M0,20-Oct-14,MLH1,Positive,Chemotherapy,1st Line,FOLFIRI,18-Aug-15,27-Oct-15,18-Nov-15,,,,Dead,10-Feb-16,Primary Cancer,14-Jul-15,Lung
CR-059,63,15-Apr-52,25705,13-Oct-14,1003,116,F,1,WHITE,C180,"Adenocarcinoma, NOS",2,IIIC,12,30,6,T4b,N2a,MX,M0,20-Oct-14,MLH1,Positive,Chemotherapy,1st Line,Bevacizumab                                                             ,1-Sep-15,27-Oct-15,18-Nov-15,,,,Dead,10-Feb-16,Primary Cancer,14-Jul-15,Lung
CR-059,63,15-Apr-52,25705,13-Oct-14,1003,116,F,1,WHITE,C180,"Adenocarcinoma, NOS",2,IIIC,12,30,6,T4b,N2a,MX,M0,20-Oct-14,MSH2,Negative,Chemotherapy,1st Line,FOLFIRI,18-Aug-15,27-Oct-15,,,,,Dead,10-Feb-16,Primary Cancer,14-Jul-15,Lung
CR-059,63,15-Apr-52,25705,13-Oct-14,1003,116,F,1,WHITE,C180,"Adenocarcinoma, NOS",2,IIIC,12,30,6,T4b,N2a,MX,M0,20-Oct-14,MSH2,Negative,Chemotherapy,1st Line,Bevacizumab                                                             ,1-Sep-15,27-Oct-15,,,,,Dead,10-Feb-16,Primary Cancer,14-Jul-15,Lung
CR-059,63,15-Apr-52,25705,13-Oct-14,1003,116,F,1,WHITE,C180,"Adenocarcinoma, NOS",2,IIIC,12,30,6,T4b,N2a,MX,M0,24-Oct-14,BRAF,Positive,Chemotherapy,1st Line,FOLFIRI,18-Aug-15,27-Oct-15,,,,,Dead,10-Feb-16,Primary Cancer,14-Jul-15,Lung
CR-059,63,15-Apr-52,25705,13-Oct-14,1003,116,F,1,WHITE,C180,"Adenocarcinoma, NOS",2,IIIC,12,30,6,T4b,N2a,MX,M0,24-Oct-14,BRAF,Positive,Chemotherapy,1st Line,Bevacizumab                                                             ,1-Sep-15,27-Oct-15,,,,,Dead,10-Feb-16,Primary Cancer,14-Jul-15,Lung
CR-059,63,15-Apr-52,25705,13-Oct-14,1003,116,F,1,WHITE,C180,"Adenocarcinoma, NOS",2,IIIC,12,30,6,T4b,N2a,MX,M0,20-Oct-14,MSH6,Negative,Chemotherapy,1st Line,FOLFIRI,18-Aug-15,27-Oct-15,,,,,Dead,10-Feb-16,Primary Cancer,14-Jul-15,Lung
CR-059,63,15-Apr-52,25705,13-Oct-14,1003,116,F,1,WHITE,C180,"Adenocarcinoma, NOS",2,IIIC,12,30,6,T4b,N2a,MX,M0,20-Oct-14,MSH6,Negative,Chemotherapy,1st Line,Bevacizumab                                                             ,1-Sep-15,27-Oct-15,,,,,Dead,10-Feb-16,Primary Cancer,14-Jul-15,Lung
CR-059,63,15-Apr-52,25705,13-Oct-14,1003,116,F,1,WHITE,C180,"Adenocarcinoma, NOS",2,IIIC,12,30,6,T4b,N2a,MX,M0,20-Oct-14,PMS2,Positive,Chemotherapy,1st Line,FOLFIRI,18-Aug-15,27-Oct-15,,,,,Dead,10-Feb-16,Primary Cancer,14-Jul-15,Lung
CR-059,63,15-Apr-52,25705,13-Oct-14,1003,116,F,1,WHITE,C180,"Adenocarcinoma, NOS",2,IIIC,12,30,6,T4b,N2a,MX,M0,20-Oct-14,PMS2,Positive,Chemotherapy,1st Line,Bevacizumab                                                             ,1-Sep-15,27-Oct-15,,,,,Dead,10-Feb-16,Primary Cancer,14-Jul-15,Lung
CR-059,63,15-Apr-52,25705,13-Oct-14,1003,116,F,1,WHITE,C180,"Adenocarcinoma, NOS",2,IIIC,12,30,6,T4b,N2a,MX,M0,20-Oct-14,MLH1,Positive,Radiation,2nd Line,,8-Dec-15,28-Dec-15,04-Feb-16,External Beam,3250,,Dead,10-Feb-16,Primary Cancer,14-Jul-15,Lung
CR-059,63,15-Apr-52,25705,13-Oct-14,1003,116,F,1,WHITE,C180,"Adenocarcinoma, NOS",2,IIIC,12,30,6,T4b,N2a,MX,M0,20-Oct-14,MSH2,Negative,Radiation,2nd Line,,8-Dec-15,28-Dec-15,,External Beam,3250,,Dead,10-Feb-16,Primary Cancer,14-Jul-15,Lung
CR-059,63,15-Apr-52,25705,13-Oct-14,1003,116,F,1,WHITE,C180,"Adenocarcinoma, NOS",2,IIIC,12,30,6,T4b,N2a,MX,M0,24-Oct-14,BRAF,Positive,Radiation,2nd Line,,8-Dec-15,28-Dec-15,,External Beam,3250,,Dead,10-Feb-16,Primary Cancer,14-Jul-15,Lung
CR-059,63,15-Apr-52,25705,13-Oct-14,1003,116,F,1,WHITE,C180,"Adenocarcinoma, NOS",2,IIIC,12,30,6,T4b,N2a,MX,M0,20-Oct-14,MSH6,Negative,Radiation,2nd Line,,8-Dec-15,28-Dec-15,,External Beam,3250,,Dead,10-Feb-16,Primary Cancer,14-Jul-15,Lung
CR-059,63,15-Apr-52,25705,13-Oct-14,1003,116,F,1,WHITE,C180,"Adenocarcinoma, NOS",2,IIIC,12,30,6,T4b,N2a,MX,M0,20-Oct-14,PMS2,Positive,Radiation,2nd Line,,8-Dec-15,28-Dec-15,,External Beam,3250,,Dead,10-Feb-16,Primary Cancer,14-Jul-15,Lung
CR-059,63,15-Apr-52,25705,13-Oct-14,1003,116,F,1,WHITE,C180,"Adenocarcinoma, NOS",2,IIIC,12,30,6,T4b,N2a,MX,M0,20-Oct-14,MLH1,Positive,Chemotherapy,Adjuvant,FOLFOX,15-Dec-14,23-Jun-15,,,,,Dead,10-Feb-16,Primary Cancer,14-Jul-15,Lung
CR-059,63,15-Apr-52,25705,13-Oct-14,1003,116,F,1,WHITE,C180,"Adenocarcinoma, NOS",2,IIIC,12,30,6,T4b,N2a,MX,M0,20-Oct-14,MSH2,Negative,Chemotherapy,Adjuvant,FOLFOX,15-Dec-14,23-Jun-15,,,,,Dead,10-Feb-16,Primary Cancer,14-Jul-15,Lung
CR-059,63,15-Apr-52,25705,13-Oct-14,1003,116,F,1,WHITE,C180,"Adenocarcinoma, NOS",2,IIIC,12,30,6,T4b,N2a,MX,M0,24-Oct-14,BRAF,Positive,Chemotherapy,Adjuvant,FOLFOX,15-Dec-14,23-Jun-15,,,,,Dead,10-Feb-16,Primary Cancer,14-Jul-15,Lung
CR-059,63,15-Apr-52,25705,13-Oct-14,1003,116,F,1,WHITE,C180,"Adenocarcinoma, NOS",2,IIIC,12,30,6,T4b,N2a,MX,M0,20-Oct-14,MSH6,Negative,Chemotherapy,Adjuvant,FOLFOX,15-Dec-14,23-Jun-15,,,,,Dead,10-Feb-16,Primary Cancer,14-Jul-15,Lung
CR-059,63,15-Apr-52,25705,13-Oct-14,1003,116,F,1,WHITE,C180,"Adenocarcinoma, NOS",2,IIIC,12,30,6,T4b,N2a,MX,M0,20-Oct-14,PMS2,Positive,Chemotherapy,Adjuvant,FOLFOX,15-Dec-14,23-Jun-15,,,,,Dead,10-Feb-16,Primary Cancer,14-Jul-15,Lung
CR-060,68,21-Jan-41,25706,2-Apr-08,1020,116,M,1,WHITE,C187,"Adenocarcinoma, NOS",3,IIIB,8,22,5,T3,N2,,M0,,,,Chemotherapy,1st Line,FOLFOX,29-Jun-10,29-Jun-10,,,,,Dead,12-Jul-10,Primary Cancer,4-May-10,Soft Tissue
CR-060,68,21-Jan-41,25706,2-Apr-08,1020,116,M,1,WHITE,C187,"Adenocarcinoma, NOS",3,IIIB,8,22,5,T3,N2,,M0,,,,Chemotherapy,Adjuvant,,,,,,,Patient choice,Dead,12-Jul-10,Primary Cancer,4-May-10,Soft Tissue
CR-061,23,5-May-93,25707,18-Jun-15,1037,132,F,1,WHITE,C180,"Adenocarcinoma, NOS",3,IIIC,11,27,6,T4a,N2a,MX,M0,18-Jun-15,PIK3CA,Positive,Chemotherapy,,,,,,,,Patient expired prior to starting treatment,Dead,7-Jul-15,Unrelated to Disease,,
CR-061,23,5-May-93,25707,18-Jun-15,1037,132,F,1,WHITE,C180,"Adenocarcinoma, NOS",3,IIIC,11,27,6,T4a,N2a,MX,M0,18-Jun-15,BRAF,Positive,Chemotherapy,,,,,,,,Patient expired prior to starting treatment,Dead,7-Jul-15,Unrelated to Disease,,
CR-061,23,5-May-93,25707,18-Jun-15,1037,132,F,1,WHITE,C180,"Adenocarcinoma, NOS",3,IIIC,11,27,6,T4a,N2a,MX,M0,18-Jun-15,NRAS,Negative,Chemotherapy,,,,,,,,Patient expired prior to starting treatment,Dead,7-Jul-15,Unrelated to Disease,,
CR-061,23,5-May-93,25707,18-Jun-15,1037,132,F,1,WHITE,C180,"Adenocarcinoma, NOS",3,IIIC,11,27,6,T4a,N2a,MX,M0,18-Jun-15,MSH2,Negative,Chemotherapy,,,,,,,,Patient expired prior to starting treatment,Dead,7-Jul-15,Unrelated to Disease,,
CR-061,23,5-May-93,25707,18-Jun-15,1037,132,F,1,WHITE,C180,"Adenocarcinoma, NOS",3,IIIC,11,27,6,T4a,N2a,MX,M0,18-Jun-15,KRAS,Negative,Chemotherapy,,,,,,,,Patient expired prior to starting treatment,Dead,7-Jul-15,Unrelated to Disease,,
CR-061,23,5-May-93,25707,18-Jun-15,1037,132,F,1,WHITE,C180,"Adenocarcinoma, NOS",3,IIIC,11,27,6,T4a,N2a,MX,M0,18-Jun-15,MLH1,Positive,Chemotherapy,,,,,,,,Patient expired prior to starting treatment,Dead,7-Jul-15,Unrelated to Disease,,
CR-061,23,5-May-93,25707,18-Jun-15,1037,132,F,1,WHITE,C180,"Adenocarcinoma, NOS",3,IIIC,11,27,6,T4a,N2a,MX,M0,18-Jun-15,MSH6,Negative,Chemotherapy,,,,,,,,Patient expired prior to starting treatment,Dead,7-Jul-15,Unrelated to Disease,,
CR-061,23,5-May-93,25707,18-Jun-15,1037,132,F,1,WHITE,C180,"Adenocarcinoma, NOS",3,IIIC,11,27,6,T4a,N2a,MX,M0,18-Jun-15,PMS2,Positive,Chemotherapy,,,,,,,,Patient expired prior to starting treatment,Dead,7-Jul-15,Unrelated to Disease,,
CR-062,49,22-May-61,25708,12-May-09,1054,144,F,1,WHITE,C180,"Adenocarcinoma, NOS",3,IIIC,5,41,24,T4b,N2,MX,M0,2-Jul-13,KRAS,Negative,Chemotherapy,1st Line,,,,,,,Patient expired prior to starting treatment,Dead,1-Aug-13,Complications of Treatment,2-Jul-13,Lung
CR-062,49,22-May-61,25708,12-May-09,1054,144,F,1,WHITE,C180,"Adenocarcinoma, NOS",3,IIIC,5,41,24,T4b,N2,MX,M0,2-Jul-13,KRAS,Negative,Chemotherapy,Adjuvant,FOLFOX,11-Jun-09,11-Nov-09,,,,,Dead,1-Aug-13,Complications of Treatment,2-Jul-13,Lung
CR-062,49,22-May-61,25708,12-May-09,1054,144,F,1,WHITE,C180,"Adenocarcinoma, NOS",3,IIIC,5,41,24,T4b,N2,MX,M0,2-Jul-13,NRAS,Negative,Chemotherapy,1st Line,,,,,,,Patient expired prior to starting treatment,Dead,1-Aug-13,Complications of Treatment,2-Jul-13,Lung
CR-062,49,22-May-61,25708,12-May-09,1054,144,F,1,WHITE,C180,"Adenocarcinoma, NOS",3,IIIC,5,41,24,T4b,N2,MX,M0,2-Jul-13,NRAS,Negative,Chemotherapy,Adjuvant,FOLFOX,11-Jun-09,11-Nov-09,,,,,Dead,1-Aug-13,Complications of Treatment,2-Jul-13,Lung
CR-062,49,22-May-61,25708,12-May-09,1054,144,F,1,WHITE,C180,"Adenocarcinoma, NOS",3,IIIC,5,41,24,T4b,N2,MX,M0,2-Jul-13,BRAF,Negative,Chemotherapy,1st Line,,,,,,,Patient expired prior to starting treatment,Dead,1-Aug-13,Complications of Treatment,2-Jul-13,Lung
CR-062,49,22-May-61,25708,12-May-09,1054,144,F,1,WHITE,C180,"Adenocarcinoma, NOS",3,IIIC,5,41,24,T4b,N2,MX,M0,2-Jul-13,BRAF,Negative,Chemotherapy,Adjuvant,FOLFOX,11-Jun-09,11-Nov-09,,,,,Dead,1-Aug-13,Complications of Treatment,2-Jul-13,Lung
CR-062,49,22-May-61,25708,12-May-09,1054,144,F,1,WHITE,C180,"Adenocarcinoma, NOS",3,IIIC,5,41,24,T4b,N2,MX,M0,2-Jul-13,EGFR,Negative,Chemotherapy,1st Line,,,,,,,Patient expired prior to starting treatment,Dead,1-Aug-13,Complications of Treatment,2-Jul-13,Lung
CR-062,49,22-May-61,25708,12-May-09,1054,144,F,1,WHITE,C180,"Adenocarcinoma, NOS",3,IIIC,5,41,24,T4b,N2,MX,M0,2-Jul-13,EGFR,Negative,Chemotherapy,Adjuvant,FOLFOX,11-Jun-09,11-Nov-09,,,,,Dead,1-Aug-13,Complications of Treatment,2-Jul-13,Lung
